These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25660822)

  • 1. Lactobacillus paracasei F19 versus placebo for the prevention of proton pump inhibitor-induced bowel symptoms: a randomized clinical trial.
    Compare D; Rocco A; Sgamato C; Coccoli P; Campo SM; Nazionale I; Larussa T; Luzza F; Chiodini P; Nardone G
    Dig Liver Dis; 2015 Apr; 47(4):273-9. PubMed ID: 25660822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term treatment with probiotics in primary care patients with irritable bowel syndrome--a randomised, double-blind, placebo controlled trial.
    Begtrup LM; de Muckadell OB; Kjeldsen J; Christensen RD; Jarbøl DE
    Scand J Gastroenterol; 2013 Oct; 48(10):1127-35. PubMed ID: 23957590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: a randomized, placebo-controlled trial.
    Søndergaard B; Olsson J; Ohlson K; Svensson U; Bytzer P; Ekesbo R
    Scand J Gastroenterol; 2011 Jun; 46(6):663-72. PubMed ID: 21443416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Yoon JS; Sohn W; Lee OY; Lee SP; Lee KN; Jun DW; Lee HL; Yoon BC; Choi HS; Chung WS; Seo JG
    J Gastroenterol Hepatol; 2014 Jan; 29(1):52-9. PubMed ID: 23829297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term PPI treatment on producing bowel symptoms and SIBO.
    Compare D; Pica L; Rocco A; De Giorgi F; Cuomo R; Sarnelli G; Romano M; Nardone G
    Eur J Clin Invest; 2011 Apr; 41(4):380-6. PubMed ID: 21128930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleotide supplementation: a randomised double-blind placebo controlled trial of IntestAidIB in people with Irritable Bowel Syndrome [ISRCTN67764449].
    Dancey CP; Attree EA; Brown KF
    Nutr J; 2006 Jun; 5():16. PubMed ID: 16762076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults.
    Larsen CN; Nielsen S; Kaestel P; Brockmann E; Bennedsen M; Christensen HR; Eskesen DC; Jacobsen BL; Michaelsen KF
    Eur J Clin Nutr; 2006 Nov; 60(11):1284-93. PubMed ID: 16721394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Lactobacillus paracasei sub. paracasei F19 on abdominal symptoms in patients with symptomatic uncomplicated diverticular disease: a pilot study.
    Annibale B; Maconi G; Lahner E; De Giorgi F; Cuomo R
    Minerva Gastroenterol Dietol; 2011 Mar; 57(1):13-22. PubMed ID: 21372765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of pantoprazole delayed-release granules for oral suspension in a placebo-controlled treatment-withdrawal study in infants 1-11 months old with symptomatic GERD.
    Winter H; Kum-Nji P; Mahomedy SH; Kierkus J; Hinz M; Li H; Maguire MK; Comer GM
    J Pediatr Gastroenterol Nutr; 2010 Jun; 50(6):609-18. PubMed ID: 20400912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease.
    Orenstein SR; Hassall E; Furmaga-Jablonska W; Atkinson S; Raanan M
    J Pediatr; 2009 Apr; 154(4):514-520.e4. PubMed ID: 19054529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised clinical trial: sustained response to PPI treatment of symptoms resembling functional dyspepsia and irritable bowel syndrome in patients suffering from an overlap with erosive gastro-oesophageal reflux disease.
    Mönnikes H; Schwan T; van Rensburg C; Straszak A; Theek C; Sander P; Lühmann R
    Aliment Pharmacol Ther; 2012 Jun; 35(11):1279-89. PubMed ID: 22486552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and secondary prevention effects of the probiotics Lactobacillus paracasei or Bifidobacterium lactis on early infant eczema: randomized controlled trial with follow-up until age 3 years.
    Gore C; Custovic A; Tannock GW; Munro K; Kerry G; Johnson K; Peterson C; Morris J; Chaloner C; Murray CS; Woodcock A
    Clin Exp Allergy; 2012 Jan; 42(1):112-22. PubMed ID: 22092692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating.
    Kim HJ; Vazquez Roque MI; Camilleri M; Stephens D; Burton DD; Baxter K; Thomforde G; Zinsmeister AR
    Neurogastroenterol Motil; 2005 Oct; 17(5):687-96. PubMed ID: 16185307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Evaluate the Benefit of the Probiotic Bifidobacterium infantis 35624 in Non-Patients With Symptoms of Abdominal Discomfort and Bloating.
    Ringel-Kulka T; McRorie J; Ringel Y
    Am J Gastroenterol; 2017 Jan; 112(1):145-151. PubMed ID: 27845337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome - a randomized, double-blind, controlled study.
    Simrén M; Ohman L; Olsson J; Svensson U; Ohlson K; Posserud I; Strid H
    Aliment Pharmacol Ther; 2010 Jan; 31(2):218-27. PubMed ID: 19863495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of
    Lewis ED; Antony JM; Crowley DC; Piano A; Bhardwaj R; Tompkins TA; Evans M
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32326347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescript-Assist probiotic-prebiotic treatment for irritable bowel syndrome: a methodologically oriented, 2-week, randomized, placebo-controlled, double-blind clinical study.
    Bittner AC; Croffut RM; Stranahan MC
    Clin Ther; 2005 Jun; 27(6):755-61. PubMed ID: 16117982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
    Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.
    Kajander K; Myllyluoma E; Rajilić-Stojanović M; Kyrönpalo S; Rasmussen M; Järvenpää S; Zoetendal EG; de Vos WM; Vapaatalo H; Korpela R
    Aliment Pharmacol Ther; 2008 Jan; 27(1):48-57. PubMed ID: 17919270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.